Kohl's saw sales decline in the latest quarter while its revised outlook for the year suggested a challenging upcoming holiday period, creating a challenging setup for its next chief executive. The ...
Best Buy Co. Inc. BBY shares are down 7% in premarket trades after the retailer’s third-quarter sales and earnings came in below analysts’ estimates. Best Buy’s third-quarter net income was $273 ...
J.M. Smucker Co.’s stock SJM was up 6.5% in premarket trading on Tuesday after the food giant said its Hostess acquisition helped boost its revenue by 17% during a “strong” second quarter performance ...
The stocks of companies that make the new class of drugs to treat obesity and manage diabetes were higher across the board early Tuesday, after the Biden administration proposed a rule that would ...
Big Rock Brewery signed a new three-year agreement with a strategic partner to provide ready-to-drink and beer beverages. The Calgary, Alberta-based brewer didn't identify the partner but Tuesday said ...
Burlington guided for sales to increase between 5% and 7% in the fourth quarter. It also expects adjusted earnings per-share in the range of $3.55 to $3.75. Analysts polled by FactSet had expected ...
Dick’s Sporting Goods Inc.’s stock DKS rose 7% premarket Tuesday, after the retailer beat estimates for the third quarter and raised its guidance. The Pittsburgh-based company posted net income of ...
In the case of older Americans, that source of cash benefits was — and remains — the Supplemental Security Income (SSI) ...
While President-elect Donald Trump has tapped pro-union Rep. Lori Chavez-DeRemer to serve as secretary of his Labor ...
Zoom Video Communications shares are down 7% in premarket action after forecast-beating earnings and outlook could sti ...
Burlington Stores Inc.’s stock BURL was down 5.8% in premarket trading on Tuesday after the clothing retailer said warm weather hurt its coat sales and it said it will fall short Wall Street analyst ...
Shares of Poseida Therapeutics tripled after the company agreed to be acquired by Roche in a deal worth up to $1.5 billion. The stock was changing hands at $9.21 in premarket trading on Tuesday.